Edit |   |
---|---|
Product Name | C188-9 |
Description | A STAT3 inhibitor; binds to the STAT3 SH2 domain (Ki = 136 nM) and inhibits G-CSF-induced activation of STAT3 in patient-derived AML cells (IC50s = 8-18 µM); induces apoptosis in patient-derived AML cells (EC50s = 6-50 µM); reduces viability of HepG2, Huh7, and PLC/PRF/5 hepatoma cells (IC50s = 10.19, 11.27, and 11.83 µM, respectively); reduces hepatic Pten deletion-induced hepatic macro- and microsteatosis which reduces the development of hepatocellular carcinomas in mice at 100 mg/kg; increases muscle fiber size in a murine Lewis lung carcinoma model of cancer cachexia at 12.5 mg/kg |
Size | 50 mg |
Concentration | n/a |
Applications | n/a |
Other Names | C1889 C 188-9 GCSF Hep G2 G 2 micro steatosis hepato cellular Huh 7 STAT 3 photo tyrosyl SH 2 |
Gene, Accession, CAS # | CAS: 432001-19-9 |
Catalog # | 30928-50 |
Price | $510.00 |
Order / More Info | C188-9 from CAYMAN CHEMICAL COMPANY |
Product Specific References | n/a |